Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ResMed Inc. (RMD) vs Unity Software Inc (U) Price & Performance

ResMed Inc.Trade
Unity Software IncTrade

Price performance (Past 24H)

Key statistics

ResMed Inc. vs Unity Software Inc — how do they compare? ResMed Inc. trades at $225.92 (market cap $31.78B), while Unity Software Inc trades at $46.34 (market cap $20.20B). The key difference: ResMed Inc. is the larger of the two by market cap, and ResMed Inc. pays a 1.17% dividend while Unity Software Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and Unity Software Inc for 50 Days on average.

RMDU
Market Cap
$31.78B$20.20B
Volume
1,128,38215,432,191
Sector
HealthTechnology
52-Week High
$277.88$49.47
52-Week Low
$182.82$17.13
Typical Hold Time
51 Days50 Days
Enterprise Value
$31.14B$20.08B
Dividend Yield
1.17%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ResMed Inc.

ResMed (RMD) trades at $225.98, up 2.4% today, with a bullish technical outlook supported by moving averages and strong fundamentals. The company reported revenue of $5.15B in 2025, with net income of $1.40B and robust margins. Recent earnings beats and a dividend announcement highlight operational strength, while analyst consensus leans positive with a $242.70 price target.

Outlook remains favorable due to consistent EPS growth and market share gains, though risks include competitive pressures and ongoing legal investigations. The stock offers growth potential from healthcare demand tailwinds, but investors should monitor execution against guidance and macroeconomic factors affecting medical device spending.

Unity Software Inc

Unity Software (U) trades at $45.44, up 1.09% with bullish technical momentum and strong analyst support. The stock shows improving fundamentals with revenue stabilizing around $1.8B and narrowing losses, though profitability remains negative. Recent news highlights Meta VR partnership driving investor optimism, with technical indicators showing the stock testing resistance near $46.

Unity presents a growth story with improving cash flow and strategic partnerships, but faces execution risks amid persistent losses. With 82% analyst buy ratings and a $46.54 price target, Wall Street sees upside potential, though investors must weigh high valuation multiples against the company's path to profitability.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RMD
80% Buy20% Sell
Avg holding period · 51 Days
U

No sentiment data available yet.

Top news

Latest headlines on both assets

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Read more on RMD →

About Unity Software Inc

Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.

Read more on U →